BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 15852786)

  • 1. [Use of intratympanic gentamycin for the treatment of Meniere's disease].
    Krzeska-Malinowska I; Pierchała K; Held-Ziółkowska M; Niemczyk K; Kowalska M
    Otolaryngol Pol; 2001; 55(6):623-6. PubMed ID: 15852786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC; Minor LB
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
    Minor LB
    Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N; Martín E; García-Tapia R
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratympanic gentamicin injection for the treatment of Meniere's disease.
    Youssef TF; Poe DS
    Am J Otol; 1998 Jul; 19(4):435-42. PubMed ID: 9661751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
    Silverstein H; Wazen J; Van Ess MJ; Daugherty J; Alameda YA
    Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benign paroxysmal positional vertigo in patients with Ménière's disease treated with intratympanic gentamycin.
    Perez N; Martin E; Zubieta JL; Romero MD; Garcia-Tapia R
    Laryngoscope; 2002 Jun; 112(6):1104-9. PubMed ID: 12160282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratympanic therapy for Ménière's disease. High-concentration gentamicin with round-window protection.
    Quaranta A; Aloisi A; De Benedittis G; Scaringi A
    Ann N Y Acad Sci; 1999 Nov; 884():410-24. PubMed ID: 10842610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of intratympanic methylprednisolone and gentamicin injection on Ménière's disease.
    Gabra N; Saliba I
    Otolaryngol Head Neck Surg; 2013 Apr; 148(4):642-7. PubMed ID: 23314159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
    Derebery MJ; Fisher LM; Berliner K; Chung J; Green K
    Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a single intratympanic gentamicin injection on Meniere's disease.
    Chung WH; Chung KW; Kim JH; Cho YS; Hong SH
    Acta Otolaryngol Suppl; 2007 Oct; (558):61-6. PubMed ID: 17882572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distortion product otoacoustic emissions after intratympanic gentamicin therapy for unilateral Ménière's disease.
    Perez N; Boleas MS; Martin E
    Audiol Neurootol; 2005; 10(2):69-78. PubMed ID: 15650298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Ménière's disease with "on-demand" intratympanic gentamicin injections.
    Manrique-Huarte R; Guillén-Grima F; Perez-Fernandez N
    Otol Neurotol; 2011 Apr; 32(3):461-5. PubMed ID: 21317673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The long-term results of treatment of Ménière's disease with intratympanic injections of gentamicin].
    Gawęcki W; Szyfter W; Lączkowska-Przybylska J; Szyfter-Harris J
    Otolaryngol Pol; 2012; 66(1):20-6. PubMed ID: 22381010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratympanic gentamicin for the treatment of Meniere's disease and other forms of peripheral vertigo.
    Carey J
    Otolaryngol Clin North Am; 2004 Oct; 37(5):1075-90. PubMed ID: 15474112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intratympanic treatment in Meniere's disease: the effect of gentamicin and dexamethasone on vertigo control and hearing].
    Akkuzu B; Ozgirgin N; Ozlüoğlu LN
    Kulak Burun Bogaz Ihtis Derg; 2006; 16(5):193-9. PubMed ID: 17124437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of intratympanic gentamicin for treatment of Ménière's disease on lower frequency hearing.
    Sam G; Chung DW; van der Hoeven R; Verweij S; Becker M
    Int J Clin Pharm; 2016 Aug; 38(4):780-3. PubMed ID: 27073077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Ménière's disease by intratympanic gentamicin application.
    Assimakopoulos D; Patrikakos G
    J Laryngol Otol; 2003 Jan; 117(1):10-6. PubMed ID: 12590850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratympanic steroid versus gentamicin for treatment of refractory Meniere's disease: A meta-analysis.
    Lee SY; Kim YS; Jeong B; Carandang M; Koo JW; Oh SH; Lee JH
    Am J Otolaryngol; 2021; 42(6):103086. PubMed ID: 34098455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratympanic gentamicin therapy for intractable Ménière's disease.
    De Beer L; Stokroos R; Kingma H
    Acta Otolaryngol; 2007 Jun; 127(6):605-12. PubMed ID: 17503229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.